PPD
PPD, a clinical research business of Thermo Fisher Scientific, is a leading provider of global contract research organization (CRO) solutions. The company is dedicated to helping clients accelerate the development of life-changing therapies through comprehensive drug development, laboratory, and lifecycle services. With a commitment to operational excellence and innovative technology, PPD empowers its customers to bring therapies to market faster and improve patient health. PPD has been recognized as an industry leader in clinical development digital transformation services and patient engagement digital transformation. With over 30 years of clinical leadership and a workforce of more than 30,000 employees globally, PPD has conducted over 2,100 trials in the past five years.
What We Do
PPD provides end-to-end, full-service solutions and customized strategies that cover every aspect of clinical testing, ensuring operational excellence throughout the clinical trial process.
PPD's laboratory services include bioanalytical, biomarkers, central lab, GMP, and vaccine sciences, designed to enhance clinical trial performance and regulatory success.
PPD offers Functional Service Provider (FSP) services for clinical trial management and post-approval marketing solutions, tailored to meet client needs.
PPD provides innovative decentralized clinical trial solutions that leverage technology to enhance patient engagement, reduce site visits, and improve trial efficiency.
PPD offers comprehensive early phase clinical trial services, leveraging a global network to navigate Phase I studies effectively.
PPD provides full-service product development for Phase II-IV clinical research studies for investigational new drugs, biologics, and medical devices.
Services
Show More (7)Digital Health Technologies
Show More (4)Infectious Diseases
Application Area
Show More (3)Biologics
Medical Devices
News & Updates
Meet with our team at the ASH Annual Meeting in San Diego, California, on Dec. 7-9, 2024.
A survey of 150 leaders at biotech and pharmaceutical organizations assessing trends, challenges, and sentiments in drug discovery and development.
Insights from 150 global drug development leaders illuminate industry trends, challenges, and sentiments.
PPD was named 'Best Vaccine CRO of the Year' at the Asia Pacific Vaccine Excellence Awards 2023, recognizing its contributions to vaccine development.
For the 12th consecutive year, PPD received the CRO Leadership Award, recognizing excellence in various categories.
PPD was recognized by ISG as a leader in clinical development digital transformation services and patient engagement digital transformation.